Designing universal T cell therapies: strategies to evade natural killer cells - Top-Institutions - MDSpire

Designing universal T cell therapies: strategies to evade natural killer cells

  • By

  • Omar Bushara

  • Gerald P. Linette

  • Beatriz M. Carreno

  • May 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The Wistar Institute
    The Wistar Institute

    Philadelphia, Pennsylvania

    Key Differentiators

    • Immunology

  • #2

    Baylor College of Medicine
    Baylor College of Medicine

    Houston, Texas

    Key Differentiators

    • Immunology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Immunology

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Immunology

Original Source(s)

Designing universal T cell therapies: strategies to evade natural killer cells

  • by Omar Bushara, Gerald P. Linette, Beatriz M. Carreno

  • May 20, 2026

Related Content

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer